Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2196466 | Molecular and Cellular Endocrinology | 2011 | 15 Pages |
Experimental evidence indicates that vitamin D may play a role in the defense against type 1 diabetes (T1D) as well as type 2 diabetes (T2D). Epidemiological data have established a link between vitamin D deficiency and an increased incidence of both T1D and T2D, whereas early and long-term vitamin D supplementation may decrease the risk of these disorders. The protective effects of vitamin D are mediated through the regulation of several components such as the immune system and calcium homeostasis. However, an increasing amount of evidence suggests that vitamin D also affects beta cells directly thereby rendering them more resistant to the types of cellular stress encountered during T1D and T2D. This review evaluates the role of vitamin D signaling in the pathogenesis of T1D and T2D with a special emphasis on the direct effects of vitamin D on pancreatic beta cells.
► Pancreatic beta cells express vitamin D receptor and other proteins involved in vitamin D signaling. ► Vitamin D supplementation restores insulin secretion from islets of deficient animal models. ► 1,25-dihydroxyvitamin D3 may protect beta cells from cytokine-induced functional impairment and cell death. ► Vitamin D deficiency has been associated with an increased risk of type 1 and type 2 diabetes. ► Intervention studies suggest a role for vitamin D in prevention and possibly in treatment of type 1 and type 2 diabetes.